Niederdeppe, J., Kellogg, M., Skurka, C., & Avery, R. J. (in press). Market-level exposure to state antismoking media campaigns and public support for tobacco control policy in the United States, 2001-2002. Tobacco Control.
Avery, R. J., Eisenberg, M., & Cantor, J (in press). An Examination of Structure-Function Claims in Dietary Supplement Advertising in the U.S.: 2003-2009. Preventative Medicine.
Niederdeppe, J., Avery, R. J., Kellogg, M., & Mathios, A. (in press). Mixed messages, mixed outcomes: Exposure to direct-to-consumer pharmaceutical advertising for statin drugs is associated with more frequent exercise and fast food visits. Health Communication.
Niederdeppe, J., Avery, R. J., Byrne, S., Siam, T. (2016). Variations in State Use of Anti-Tobacco Message Themes Predict Youth Smoking Prevalence in the United States, 1999-2005. Tobacco Control doi:10.1136/tobaccocontrol-2014-051836.
Kruger, C., Niederdeppe, J., Byrne, S., & Avery, R. (2015). Effects of exposure to direct-to-consumer television advertising for statin drugs on food and exercise guilt. Patient Education and Counseling, 98, 1150-1155.
Niederdeppe, J., Byrne, S., Avery, R., & Cantor, J. (2013). Exposure to direct-to-consumer pharmaceutical advertising, diagnosis with high cholesterol, and statin use. Journal of General Internal Medicine, 28(7), 886-893.
Byrne, S., Niederdeppe, J., Avery, R., & Cantor, J. (2013). When diet and exercise are not enough: An examination of lifestyle change inefficacy claims in direct-to-consumer advertising. Health Communication, 28(8), 800-813.
Avery, R. J., Cawley, J., & Eisenberg, M. (2013). Raising Red Flags: The Change in Deceptive Advertising of Weight Loss Products After the Federal Trade Commission’s 2003 Red Flag Initiative. Journal of Public Policy and Marketing, 23(1), 129-139.
Avery, R. J., Simon, K., & Eisenberg, M. (2013). The Impact of Direct to Consumer Print and Television Advertising on Antidepressant Use. Journal of Health Economics, 31(5):705-18.